GHK-Cu for hormonal acne: what the evidence actually shows

What did @mandilima_777 actually say?

The transcript provided appears to be corrupted or mismatched audio, so we're working primarily from the caption. According to the post, the creator experienced active back acne triggered by a hormonal change, started using GHK-Cu, and claims that within two weeks the active, inflamed lesions dried up completely. She writes that the marks were "ativas e inflamadas" (active and inflamed) before, and now everything has "secado" (dried out). She plans to focus next on fading the remaining hyperpigmentation marks.

That's a specific, time-bound claim: a topical or injectable copper peptide resolved hormonally driven inflammatory acne in 14 days. It's worth taking seriously, because the mechanism isn't implausible, but the conclusion she draws goes further than the data supports.

Does the science back this up?

Partly, but with important caveats. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has real, peer-reviewed anti-inflammatory and wound-remodeling properties. The evidence just doesn't cleanly extend to hormonal acne as a standalone treatment.

Pickart and Margolina (2018, Cosmetics) documented GHK-Cu's ability to suppress inflammatory cytokines including TNF-alpha and IL-6, which are directly involved in the inflammatory cascade behind acne vulgaris. Separate research by Gorouhi and Maibach (2009, Skin Pharmacology and Physiology) confirmed copper peptides accelerate wound contraction and reduce inflammation in skin barrier disruption models.

However, hormonal acne is primarily driven by androgen-stimulated sebum overproduction and Cutibacterium acnes proliferation. GHK-Cu has no documented anti-androgenic activity and limited demonstrated antibacterial effect against C. acnes specifically. A two-week resolution of hormonally triggered acne is biologically plausible due to the anti-inflammatory effects, but attributing full clearance to GHK-Cu alone, without controlling for other variables, is a reach.

What did they get wrong (or right)?

She got the anti-inflammatory angle right, even if she didn't say it in those terms. GHK-Cu genuinely reduces skin inflammation, and inflamed acne lesions responding to that mechanism is scientifically coherent. Credit where it's due.

What she got wrong, or at least oversimplified: hormonal acne doesn't just "dry up" because inflammation is suppressed. If the androgenic trigger is still active, new lesions typically continue forming. Two weeks is also within the range of natural acne cycle resolution, meaning some of this clearance may have happened without any intervention. She had no control condition.

She also doesn't specify the route of administration. Topical GHK-Cu penetration through intact skin is limited. Injectable GHK-Cu has different pharmacokinetics entirely. Those are not interchangeable, and the form she used matters a lot for evaluating her result.

The claim that it "secou todas" (dried everything) also implies a completeness that a single anecdotal report cannot establish. One person's two-week experience is not a treatment outcome.

What should you actually know?

GHK-Cu is one of the more studied peptides in the cosmetic and regenerative space, which makes it more credible than most of what circulates on TikTok. The anti-inflammatory and skin remodeling data are real. Figueiredo and colleagues (2017, Journal of Drugs in Dermatology) found copper peptides supported collagen synthesis and reduced post-inflammatory changes, which does align with her goal of fading hyperpigmentation marks afterward.

But using one person's hormonal acne response as evidence that GHK-Cu treats acne is a logical gap. Hormonal acne requires addressing the hormonal driver, usually through a clinician, not a peptide with no endocrine mechanism. If your acne is hormonally triggered, a dermatologist or endocrinologist should be part of the picture.

On a regulated platform, GHK-Cu is available in compounded topical and injectable forms. Those are not equivalent to each other or to any brand-name product. Anyone considering peptide therapy should have a clinical consultation first, full stop.